Labshake search
Citations for R&D Systems :
351 - 400 of 3208 citations for 5 Nitro 1H benzo de isoquinoline 1 3 2H dione since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2024Quote: ... Z-vad (5 µM, Pan-caspase inhibitor, R&D systems), Z-vad plus SopB (3 µg/mL ...
-
bioRxiv - Immunology 2024Quote: ... recombinant mouse IL-17A (5 ng/mL; R&D Systems); or the appropriate vehicles and carrier proteins for 24 h ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5 ng/mL bFGF (R&D Systems 233-FB-025), and 5 μL/mL Transferrin (Roche 10652202001) ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5 ng/mL VEGF (R&D Systems 293-VE-050), and 5 μL/mL Transferrin ...
-
bioRxiv - Bioengineering 2024Quote: ... which consists of 5% FCS (R&D systems, Cat #M19187), 5 ng μl−1 IL-7 ...
-
bioRxiv - Biochemistry 2024Quote: ... mouse anti-IL10RB (R&D Systems MAB874, 5 μg/ml), rabbit anti-FOXO3 (CST 2497 ...
-
bioRxiv - Cancer Biology 2022Quote: ... cocultures were treated with 3 μg/ml IL1α-neutralizing antibody (#MAB4001, R&D Systems) or isotype control antibody (#400902 ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Genomics 2021Quote: ... Polyclonal Goat Anti- Human/Mouse Oct-3/4 Antibody (R&D System, AF1759,1:20).
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Microbiology 2023Quote: Calu-3 cells were treated with exogenous β-IFN (R&D Systems, Minneapolis MN), baricitinib (Selleck Chemicals ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/ml IL-3 and 80 ng/ml M-CSF (R&D Systems). On day 13 ...
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Developmental Biology 2020Quote: ... mouse anti-Nkx2-5 (25 μg/ml, R&D Systems, #259416), rabbit anti-MYL7 (1:1000 ...
-
bioRxiv - Microbiology 2021Quote: ... 5 ng/mL BMP-4 (314-BP-050, R&D Systems), 50 ng/mL VEGF (293-VE-500 ...
-
bioRxiv - Molecular Biology 2022Quote: ... mice were treated with 5 µg RSPO3 (R&D systems #4120RS025CF) in 100 µL PBS 18 ...
-
bioRxiv - Neuroscience 2020Quote: ... SCH 23390 hydrochloride (5 μM; R&D Systems, Minneapolis, MN, USA) was added to the aCSF ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 10 ng/mL CNTF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D SYSTEMS, S11150) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2020Quote: ... and 5 μg of anti-ACE2 antibody (R&D systems, AF933) or isotope control IgG (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL HB-EGF (R&D Systems 259-HE-050), and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Neuroscience 2023Quote: ... Membranes were blocked in 5% nonfat skim milk (R&D Systems) for 1 h at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5 ng/ml BMP4 (R&D Systems, 314-BP), 50 ng/ml VEGF (R&D Systems ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5% fetal bovine serum (R&D systems; cat# S11150), 0.4 μg/ml hydrocortisone (Sigma ...
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Immunology 2024Quote: ... and 5 µg/ml anti-GM-CSF (MP122E9, R&D Systems) or 1 µg/ml anti-PECAM-1 (MEC13.3 ...
-
bioRxiv - Developmental Biology 2024Quote: ... media was replaced with 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Genetics 2024Quote: ... and 5 ng/ml recombinant human IL-15 (R&D Systems). After two days of activation ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 1X B27 supplement (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/mL GDF-5 (R&D Systems, Minneapolis, MN, USA), and 0.05 mM L-ascorbic acid 2-phosphate ...
-
bioRxiv - Microbiology 2020Quote: ... phosphorylated CREB (pCREB) and cleaved caspase-3 were measured using ELISA kits (R&D Systems) according to the manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Cell Biology 2022Quote: ... then plated into T175 flasks with Interleukin-3 (IL3, R&D Systems, 203-IL-050) and macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Cell Biology 2023Quote: Primary antibodies used for immunofluorescent staining were: active caspase-3 (Rabbit, R&D Systems, AF835); laminin alpha3 chain (Mouse ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5 ng/mL IL-12 (R&D Systems, cat#219-IL-005), 10 ng/mL IL-15 (NCI preclinical repository) ...
-
bioRxiv - Cell Biology 2020Quote: ... PE anti-human ULBP-2/5/6 (Clone 165903, R&D Systems), FITC Mouse IgG1 κ Isotype Control (Clone MOPC-21 ...
-
bioRxiv - Immunology 2022Quote: ... or NKG2D neutralizing antibody (5 µg/ml, R&D Systems, MAB139-100); ILC1-like cells demonstrated cytotoxic effect on HFs with 600 cells per well ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Neuroscience 2024Quote: ... myogenic factor 5 (MYF5) (mouse monoclonal, MAB4027, R&D Systems, Minneapolis, USA), myosin heavy chain (MYHC ...
-
bioRxiv - Immunology 2024Quote: ... IL-5 and IL-13 were measured by ELISA (R&D systems). Results were normalized to cell number using CyQuant cell proliferation assay (Invitrogen ...
-
Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutationsbioRxiv - Genomics 2024Quote: ... or 5 µg of AREG neutralizing antibody (R&D Systems, MAB262-SP) or an equivalent volume of PBS ...